A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients ...

Low-dose aspirin use was linked to a 55% lower risk of colorectal cancer recurrence in people with a genetic mutation that ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer than those without IBD, according to a Danish cohort study published in The ...

Colorectal cancer is the second most common cause of cancer-related death in women and the third most common in men. Since the 1980s, the incidence of colorectal cancer in individuals aged 50 and ...

A new study finds that the common over-the-counter medication Aspirin could significantly cut the risk of colorectal cancer ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic ...

Taken together with previous observational, genomic, and early trial data, our findings support the integration of aspirin into clinical practice for a molecularly defined subgroup of patients with ...

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in genetically defined patients. A team of researchers led by Karolinska Institutet and Karolinska University Hospital has demonstra ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer recurrence by approximately 55% in patients with specific PI3K pathway mutations.